Stephane Altaba Email & Phone Number

Paris, Fr

Grenoble, Auvergne-Rhône-Alpes, Fr

Bagneux, Paris Area, Fr

- Restructuring of the company into 3 Business Units - Strategic partnerships set up with Harvard Med. School (Boston), Giptis (Marseille), CMRI (Sidney), and Sanofi (Paris)- COVID 19 diagnostic test distribution agreement signed with a major player in the field- +60% sales growth achieved in 2019 vs 2018

Bagneux, Paris Area, Fr

Head of Corporate Business Development and Commercial OperationsMember of the Management Board (2017)- Sales increased tenfold in 2 years fom 0,2M€ in 2015 to 2,1M€ in 2017. - New strategic activity in Life Science Research launched (Replication and Genome Editing) and first plateforms installed in US (ex Quest Diagnostics) and in China- Oversaw Alliance Management the strategic partnership Genomic Vision - Quest Diagnostic - R&D collaboration deal signed with Editas Medecine, Boston

Paris, Île De France, Fr

Member of the Nordic Pharma Group Executive Committee, chaired by the Nordic CEO and comprised of four vice presidents- Defining and implementing corporate development through strategic partnerships- Assessing opportunities for external growth and optimization of the Nordic product portfolio- Overseeing Nordic’s territorial strategy to expand outside of Europe (export countries, US and Japan)

Paris, Île De France, Fr

Member of the Nordic Operations committee• Created the Nordic product portfolio through more than 20 major licensing deals (accounting for more than 50% of the Group’s sales by 2018) in Oncology, Haematology, Gynaecology, Rheumatology and Critical care - Oversaw Alliance management for main partnerships including the Taiho-Nordic collaboration - Creation of the Nordic Corporate Oncology BU and set up the Taiho Oncology office in Paris following strategic partnership signed with the japanese company- Established the Nordic affiliates in Spain (2013) and Switzerland through local company acquisitions

Hoofddorp, North Holland, Nl

In charge of Nordic Italy affiliate and member of the board - Successfully built the company from scratch and launched the Gynaecology and the Oncology products

Paris, France, Fr

Member of the Corp. Bus. Dev. & Lic. Meeting Review Committee. In charge of the Oncology therapeutic area - Supervised reviews, due diligence and negotiations leading to the signature of a 300M€ major partnership- Oversaw renegotiations of existing agreements between Sanofi Aventis France and Japanese companies

Paris, France, Fr

Senior Manager, Business Development. Member of Operations Commitee managing more than €300M in sales- Supervised the Alliance management of licensed products for the BU, including for Aventis/Astra-Zeneca Zoltum®-Mopral® co-marketing and the Aventis/Fujisawa partnership on Oroken®- Successfully closed more than 10 major divestment deals under the supervision of top management

Paris, France, Fr

Worked in the Biochemistry Process Development Department- Coordinated the European Research Project on Nitrogen Metabolic Engineering (4th EU Framework Program)- Contributed to successful Synercid ® Pre approval inspection by FDA at the Vitry site

Wako , Saitama, Jp

Chemical Engineering Lab. of Pr. EndoWorked as part of a fellowship awarded by the Japanese Science and Technology Agency for a research program on expert system for fermentation control.

Minato-Ku, Tokyo, Jp

Scientific Attaché Worked on a specific mission for the Lafarge Coppée group and the U.I. Japan private investment fundPublished several articles on Biotechnology in Japan in BIOFUTUR magazine

Ph.D. in Biotechnology, funded by the CNRS and ORSAN Company (Optimization Modelling and economic analysis of Lactic acid Fermentation in a membrane bioreactor) Publications in International Journals

Post Graduate Degree, Marketing, Controlling & Finance, General Management

Ph.D., Biochemical Engineering

Engineer'S Degree, Agronomy, Food Engineering & Biotechnology

Math Sup/Spé Bio